Glenmark Life Sciences Limited IPO (Glenmark Life Sciences IPO)

Glenmark Life Science IPO
Upcoming Glenmark Life Science IPO | Glenmark Life Science IPO 2021 | New Glenmark Life Science IPO | Glenmark IPO | Glenmark Life IPO

Compiled in 2011, Glenmark Life Sciences is a leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company builds, manufactures, and provides high-quality APIs for heart disease (CVS), central nervous system (CNS), pain management, and diabetes, intestinal disorders, anti-infectives and other therapies. It continues to operate Contract Development and Manufacturing Services (CDMO) to provide services to specialized Pharmaceutical companies.

Its products are sold in India and exported to many countries namely Europe, North America, Latin America, Japan, etc. Currently, it has 4 production facilities in Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State annually with an installed capacity of 725.8 KL from December 31, 2020.

Glenmark Life Science IPO

Competitive Strengths

  • Leading manufacturer of selected specialized APIs for chronic therapeutic areas like CVS, CNS, diabetes, and pain management.
  • Export products in Europe, Latin America, North America, Japan, and the rest of the world.
  • Strong relationship with leading global generic companies.
  • Proven track record of strong financial performance.
  • High-quality product manufacturing with R&D infrastructure.

Company Promoters

Glenmark Pharmaceuticals Limited is the promoter of the company.

Company Financials

ParticularsFor the year/period ended (₹ in million)
31-Mar-2131-Mar-2031-Mar-19
Total Assets19,970.7517,256.0414,753.95
Total Revenue18,859.7615,493.038,868.65
Profit After Tax3,515.813,130.981,955.92

Objects of the Issue

  • To make payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company.
  • To finance capital expenditure requirements.
  • To meet general corporate purposes.

Glenmark Life Sciences IPO – Details

IPO Opening DateJuly 27, 2021
IPO Closing DateJuly 29, 2021
Issue TypeBook Built Issue IPO
Issue Size1000 Cr Fresh Issue + 450 Crore Offer For Sale
Face Value₹2 per equity share
IPO Price[695] To [720] Per Equity Share
Market Lot20 Shares
Min Order Quantity20 Shares
Listing AtBSE SME
Total Share Issue63,00,000 Equity Shares
RegisterKFintech Private Limited

Glenmark Life Sciences IPO – Timetable

IPO Open DateJul 27, 2021
IPO Close DateJul 29, 2021
Basis of Allotment DateAug 03, 2021
Initiation of RefundsAug 04, 2021
Credit of Shares to Demat AccountAug 05, 2021
IPO Listing DateAug 06, 2021

Glenmark Life Sciences IPO Lots Size & Price

ApplicationLotsSharesAmount ( Cut-Off)
Minimum12014,400
Maximum132601,87,200

Company Contact Information

Glenmark Life Sciences Limited
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213,

Phone: +91 2189 234456/ +91 2189
Email: complianceofficer@glenmarklifesciences.com
Websitehttp://www.glenmarklifesciences.com/

Glenmark Life Sciences IPO FAQs

What is Glenmark Life Sciences IPO?

Glenmark Life Sciences IPO is a main-board IPO of [.] equity shares of the face value of ₹2 aggregating up to ₹[.] Crores. The issue is priced at [.] to [.] per equity share. The minimum order quantity is .

The IPO opens on Jul 27, 2021, and closes on Jul 29, 2021.

KFintech Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
When Glenmark Life Sciences IPO will open?

The Glenmark Life Sciences IPO opens on Jul 27, 2021 and closes on Jul 29, 2021.
What is the lot size of Glenmark Life Sciences IPO?

Glenmark Life Sciences IPO lot size is 20 Shares and the minimum order quantity is 20 Shares.
How to apply for Glenmark Life Sciences IPO?

You can apply in Glenmark Life Sciences IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services.
When is Glenmark Life Sciences IPO listing date?

The Glenmark Life Sciences IPO listing date is Announced. The date of Glenmark Life Sciences IPO listing is Jul 06, 2021.

LIST OF UPCOMING IPOs